Nanobiotix: Monthly update of voting rights and shares

Biotechnology company Nanobiotix, listed on both Euronext Paris and Nasdaq, has released its latest share capital information. As of March 31, 2025, the company's share capital consists of 47,426,851 shares. These shares represent a total of 49,193,374 theoretical voting rights and 49,171,256 exercisable rights.

This information is shared in accordance with applicable regulations, including Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulations of the French Financial Markets Authority (AMF). Nanobiotix provides these figures to ensure a high level of transparency for investors and the public.